Medicament for treating dermatophytosis

Abstract

The invention relates to a medicament for treating dermatophytosis. The medicament is characterized by comprising the following components in parts by weight: 30-50 parts of typhonium giganteum, 6-16 parts of angelica root, 4-12 parts of saffron, 5-20 parts of decumbent bugle herb, 10-20 parts of rauvolfia latifrons, 8-20 parts of levisticum officinale, 6-18 parts of sandalwood, 20-40 parts of rhizoma atractylodis, 15-30 parts of divaricate saposhnikovia root, 5-15 parts of schizonepeta spike, 10-20 parts of dried alum, 30-50 parts of fructus cnidii, 20-40 parts of broom cypress fruit, 30-60 parts of sealwort, 40-60 parts of agastache rugosus, 5-15 parts of radix sophorae flavescentis and 5-10 parts of mint. By virtue of the medicament, dermatophytosis can be healed generally after a course of treatment, the curative effect is remarkable, and the cost is low; 80 patients of patients with dermatophytosis can be treated by using the medicament, wherein 52 patients, accounting for 65 percent, are healed after administration of one course of treatment, 24 patients, accounting for 30 percent, are healed after administration of two courses of treatment, and the situation of 4 patients, accounting for 5 percent, are controlled. The medicament has a remarkable treatment effect, and does not generate adverse responses.

Description

technical field [0001] The invention relates to a medicine for treating beriberi. Background technique [0002] Beriberi is a very common fungal infectious skin disease. 70-80% of adults have beriberi, but the severity is different. It is often aggravated in summer and alleviated in winter, and some people do not heal all the year round. At present, there are a lot of medicines for treating beriberi on the market, some of which cannot achieve the purpose of radically curing beriberi, and the cost is also higher, and the feet are also damaged to a certain extent, and the effect is not good. Contents of the invention [0003] Aiming at the problems existing in the prior art, the object of the present invention is to provide a technical scheme of medicine for treating beriberi. [0004] The medicine for treating beriberi is characterized in that it comprises the following components in parts by weight: unicorn lotus 30-50, angelica dahurica 6-16, saffron 4-12, sinensis 5-20,...

AI Technical Summary

Problems solved by technology

At present, there are many medicines for treating beriberi on the market, some of which cannot achieve the purpose of radically curing beriberi, and the cost is relatively high, and there is certain damage to the feet, and the effect is not good.